These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 825024)
1. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa. Morse SA; Vaughan P; Johnson D; Iglewski BH Antimicrob Agents Chemother; 1976 Aug; 10(2):354-62. PubMed ID: 825024 [TBL] [Abstract][Full Text] [Related]
2. Pyocin inhibition of Neisseria gonorrhoeae: mechanism of action. Morse SA; Jones BV; Lysko PG Antimicrob Agents Chemother; 1980 Sep; 18(3):416-23. PubMed ID: 6775595 [TBL] [Abstract][Full Text] [Related]
3. Pyocin sensitivity of Neisseria gonorrhoeae and its feasibility as an epidemiological tool. Sidberry HD; Sadoff JC Infect Immun; 1977 Feb; 15(2):628-37. PubMed ID: 403141 [TBL] [Abstract][Full Text] [Related]
4. Effect of environment on sensitivity of Neisseria gonorrhoeae to Pseudomonas aeruginosa bacteriocins. Stein DC; Hebeler BH; Young FE Infect Immun; 1980 Aug; 29(2):507-11. PubMed ID: 6783533 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of Neisseria gonorrhoeae to partially purified R-type pyocines and a possible approach to epidemiological typing. Blackwell CC; Young H; Anderson I J Med Microbiol; 1979 Aug; 12(3):321-35. PubMed ID: 112255 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of active transport and macromolecular synthesis by pyocin 103 in Neisseria gonorrhoeae. Stein DC; Clark VL; Young FE Sex Transm Dis; 1983; 10(1):7-13. PubMed ID: 6189200 [TBL] [Abstract][Full Text] [Related]
7. Interaction with lectins and differential wheat germ agglutinin binding of pyocin 103-sensitive and -resistant Neisseria gonorrhoeae. Connelly MC; Stein DC; Young FE; Morse SA; Allen PZ J Bacteriol; 1981 Dec; 148(3):796-803. PubMed ID: 6796562 [TBL] [Abstract][Full Text] [Related]
8. F-Type Pyocins Are Diverse Noncontractile Phage Tail-Like Weapons for Killing Saha S; Ojobor CD; Li ASC; Mackinnon E; North OI; Bondy-Denomy J; Lam JS; Ensminger AW; Maxwell KL; Davidson AR J Bacteriol; 2023 Jun; 205(6):e0002923. PubMed ID: 37260386 [TBL] [Abstract][Full Text] [Related]
9. Alteration of pyocin-sensitivity pattern of Neisseria gonorrhoeae is associated with induced resistance to killing by human serum. Winstanley FP; Blackwell CC; Tan EL; Patel PV; Parsons NJ; Martin PM; Smith H J Gen Microbiol; 1984 May; 130(5):1303-6. PubMed ID: 6432949 [TBL] [Abstract][Full Text] [Related]
10. The structural basis for pyocin resistance in Neisseria gonorrhoeae lipooligosaccharides. John CM; Griffiss JM; Apicella MA; Mandrell RE; Gibson BW J Biol Chem; 1991 Oct; 266(29):19303-11. PubMed ID: 1918047 [TBL] [Abstract][Full Text] [Related]
11. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin. Rampling A; Whitby JL; Wildy P J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999 [TBL] [Abstract][Full Text] [Related]
12. Biochemical properties of a new flexuous bacteriocin, pyocin F1, produced by Pseudomonas aeruginosa. Kuroda K; Kageyama M J Biochem; 1979 Jan; 85(1):7-19. PubMed ID: 104991 [TBL] [Abstract][Full Text] [Related]
13. Purification and properties of an S-type pyocin, pyocin AP41. Sano Y; Kageyama M J Bacteriol; 1981 May; 146(2):733-9. PubMed ID: 6783626 [TBL] [Abstract][Full Text] [Related]
14. Assessment of bacteriocin production by clinical Pseudomonas aeruginosa isolates and their potential as therapeutic agents. Charkhian H; Soleimannezhadbari E; Bodaqlouei A; Lotfollahi L; Lotfi H; Yousefi N; Shojadel E; Gholinejad Z Microb Cell Fact; 2024 Jun; 23(1):175. PubMed ID: 38872163 [TBL] [Abstract][Full Text] [Related]
15. Antigenic specificity and heterogeneity of lipopolysaccharides from pyocin-sensitive and -resistant strains of Neisseria gonorrhoeae. Connelly MC; Allen PZ Infect Immun; 1983 Sep; 41(3):1046-55. PubMed ID: 6193064 [TBL] [Abstract][Full Text] [Related]
16. Identification of an envelope mutation (env-10) resulting in increased antibiotic susceptibility and pyocin resistance in a clinical isolate of Neisseria gonorrhoeae. Shafer WM; Guymon LF; Lind I; Sparling PF Antimicrob Agents Chemother; 1984 Jun; 25(6):767-9. PubMed ID: 6430226 [TBL] [Abstract][Full Text] [Related]
17. [Pyocin production by bacillus pyocyaneus and sensitivity of strains of different origin to them]. Kurnosova LM; Sukhodol'skaia AE; Suvorova TI; Faustova VA Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):8-13. PubMed ID: 6776722 [TBL] [Abstract][Full Text] [Related]
18. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate. Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427 [TBL] [Abstract][Full Text] [Related]
19. Comparative study on R-type pyocins of Pseudomonas aeruginosa. Ohsumi M; Shinomiya T; Kageyama M J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248 [TBL] [Abstract][Full Text] [Related]
20. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile]. García-Quintana HG; Polette M; Ríos J Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]